Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,795 articles
The European Society of Endocrinology issues comprehensive 2025 clinical guidelines for managing menopause, perimenopause, and premature ovarian insufficiency.
A 34-country study of 18,701 people finds environmental and social exposures accelerate brain aging more than Alzheimer's or dementia diagnoses.
A 2025 review finds 30–50% of adults over 71 eat too little protein, accelerating muscle loss, immune decline, and frailty.
Scientists reversed aging in blood stem cells by targeting hyperactive lysosomes, boosting repopulation capacity over eightfold and restoring youthful function.
A 25-year Lancet study finds adults over 40 with obesity now show cardiovascular markers rivaling normal-weight peers, thanks to medications.
From a 20% lifespan boost in mice to Alzheimer's glycosylation hallmarks, June's research roundup delivers dense longevity science.
A new review reveals how the deadenylase PARN governs telomerase RNA maturation, linking RNA decay to telomere length, aging, and disease.
An AI-engineered antisense oligonucleotide slashes toxic progerin levels, reverses cardiovascular damage, and dramatically extends lifespan in progeria models.
A large multi-omics study confirms sarcopenia and osteoporosis fuel each other — and share genetic, protein, and metabolic pathways.
A targeted RNA therapy reverses hematopoietic decline in aged mice and human stem cells by silencing a key telomere-driven damage pathway.
A newly identified protein in blood vessel walls slows vascular aging in mice — and gene therapy targeting it shows promising results.
A comprehensive 2025 review maps the mechanisms behind MSC senescence and surveys emerging rejuvenation strategies for cell-based therapies.
